# Antibiotic Treatment in Ventilator Associated Tracheobronchitis (VAT)

> **NCT01027832** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Tracheobronchitis

## Interventions

- **DRUG:** Piperacillin/Tazobactam for 7 days

## Key facts

- **NCT ID:** NCT01027832
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2011-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01027832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01027832, "Antibiotic Treatment in Ventilator Associated Tracheobronchitis (VAT)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01027832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*